References
- Azevedo LG, Muccillo-Baisch AL, Filgueira DM, Boyle RT, Ramos DF, Soares AD, Lerner C, Silva PA, Trindade GS (2008): Comparative cytotoxic and anti-tuberculosis activity of Aplysina caissara marine sponge crude extracts. Comp Biochem Physiol C Toxicol Pharmacol 147: 36–42.
- Bazin MA, Lamer AC, Delcros JG, Rouaud I, Uriac P, Boustie J, Corbel JC, Tomasi S (2008): Synthesis and cytotoxic activities of usnic acid derivatives. Bioorg Med Chem 16: 6860–6866.
- Cocchietto M, Skert N, Nimis PL, Sava G (2002): A review on usnic acid, an interesting natural compound. Naturwissenschaften 89: 137–146.
- Copp BR, Pearce AN (2007): Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep 24: 278–297.
- De Carvalho EA, Andrade PP, Silva NH, Pereira EC, Figueiredo RC (2005): Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: An ultrastructural study. Micron 36: 155–161.
- Fazio AT, Adler MT, Bertoni MD, Sepulveda CS, Damonte EB, Maier MS (2007): Lichen secondary metabolites from the cultured lichen mycobionts of Teloschistes chrysophthalmus and Ramalina celastri and their antiviral activities. Z Naturforsch C 62: 543–549.
- Garcia-Navarro X, Barnadas MA, Dalmau J, Coll P, Gurgui M, Alomar A (2008): Mycobacterium abscessus infection secondary to mesotherapy. Clin Exp Dermatol 5: 658–659.
- Han D, Matsumaru K, Rettori D, Kaplowitz N (2004): Usnic acid-induced necrosis of cultured mouse hepatocytes: Inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol. 67: 439–451.
- Hsieh HC, Lu PL, Chen TC, Chang K, Chen YH (2008): Mycobacterium chelonae empyema in an immunocompetent patient. J Med Microbiol 57: 664–667.
- Ingólfsdóttir K, Chung GA, Skulason VG, Gissurarson SR, Vilhelmsdottir M (1998): Antimycobacterial activity of lichen metabolites in vitro. Eur J Pharm; 6: 141–144
- Ingólfsdóttir K (2002): Usnic acid. Phytochemistry 61: 729–736.
- Jarzembowski JA, Young MB (2008): Nontuberculous mycobacterial infections. Arch Pathol Lab Med 8: 1333–1341
- Mata R, Morales I, Perez O, Rivero-Cruz I, Acevedo L, Enriquez-Mendoza I, Bye R, Franzblau S, Timmermann B (2004): Antimycobacterial compounds from Piper sanctum. J Nat Prod 67: 1961–1968.
- Okunade AL, Elvin-Lewis MP, Lewis WH (2004): Natural antimycobacterial metabolites: Current status. Phytochemistry 65: 1017–1032.
- Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F (2002): Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 46: 2720–2722.
- Pauli GF, Case RJ, Inui T, Wang Y, Cho S, Fischer NH, Franzblau SG (2005): New perspectives on natural products in TB drug research. Life Sci 78: 485–494.
- Reddy VC, Prasad CE, Aparna S, Gokhale S, Anjeneyulu (2008): A study of mycobacterial species causing lymphadenitis. Southeast Asian J Trop Med Public Health 39: 130–135.
- Rojas R, Caviedes L, Aponte JC, Vaisberg AJ, Lewis WH, Lamas G, Sarasara C, Gilman RH, Hammond GB (2006): Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. J Nat Prod 69: 845–846.
- Shibata S, Ukita T, Tamura T, Miura Y (1948): Relation between chemical constitutions and antibacterial effects of usnic acid and derivates. Jap Med J 1: 152–155.
- Stavri M, Mathew KT, Bucar F, Gibbons S (2003): Pangelin, an antimycobacterial coumarin from Ducrosia anethifolia. Planta Med 69: 956–959.
- Stoll A, Brack A, Renz J (1950): The effect of lichenic substances on the tubercle bacillus and certain other microorganisms; seventh article on antibacterial substances. Schweiz Z Pathol Bakteriol 13: 729–751.
- Vijayakumar CS, Viswanathan S, Reddy MK, Parvathavarthini S, Kundu AB, Sukumar E (2000): Anti-inflammatory activity of (+)-usnic acid. Fitoterapia 71: 564–566.
- WHO REPORT (2008): Global tuberculosis control-survellance, planning, financing. Geneve, WHO/HTM/TB.2008. 393: 15–45.